XML 40 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Corlieve transaction - Narrative (Details)
€ in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Jul. 30, 2021
USD ($)
Institution
employee
Jul. 30, 2021
EUR (€)
Sep. 30, 2021
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2021
EUR (€)
Sep. 30, 2021
EUR (€)
Jul. 30, 2021
EUR (€)
Institution
employee
Dec. 31, 2020
USD ($)
Business Acquisition [Line Items]                
Contingent consideration     $ 23,781 $ 23,781        
Enacted tax rate     25.00% 25.00% 25.00%      
Goodwill     $ 28,060 $ 28,060       $ 542
Repayment of debt acquired through acquisition of Corlieve       1,175        
Acquired research & development                
Business Acquisition [Line Items]                
Acquired in-process research and development intangible asset     61,734 61,734        
Acquisition of Corlieve                
Business Acquisition [Line Items]                
Number of institutions | Institution 2           2  
Number of employees employed | employee 7           7  
Percentage of outstanding ordinary shares 97.70%           97.70%  
Value of shares issued $ 53,300 € 44,900            
Amount of liability related to mandatorily redeemable shares 900           € 700  
Contingent consideration $ 23,950   23,781 23,781     € 20,200  
Fair value of contingent consideration     23,800 23,800   € 20,500    
Weighted average cost of capital 10.40%           10.40%  
Provisional fair value of IPR&D intangible asset $ 63,300           € 53,300  
Deferred tax assets 2,200           1,800  
Intangible assets $ 15,800           13,300  
Enacted tax rate 25.00% 25.00%            
Deferred tax liability, net $ 13,600           11,500  
Goodwill 28,200           23,770  
Repayment of debt acquired through acquisition of Corlieve       $ 1,200 € 1,000      
Acquisition of Corlieve | Maximum                
Business Acquisition [Line Items]                
Consideration payable in development milestones through phase I or II 42,500           35,800  
Consideration payable in development milestones through phase III $ 169,900           € 143,100  
Percentage of milestones payable through the issuance of shares 25.00% 25.00%            
Acquisition of Corlieve | Increase Probability of Success                
Business Acquisition [Line Items]                
Percentage of increase in Probability of Success 5.00% 5.00%   5.00% 5.00%      
Increase in fair market of contingent consideration $ 1,900     $ 1,900        
Fair value of contingent consideration 25,900   25,700 25,700        
Acquisition of Corlieve | Reduction in the estimated timing of achieving such milestones                
Business Acquisition [Line Items]                
Increase in fair market of contingent consideration 1,300     1,300        
Fair value of contingent consideration $ 25,300   $ 25,100 $ 25,100        
Term of reduction in achieving milestones 6 months 6 months   6 months 6 months